Clinical Variants of New Delhi Metallo-β-Lactamase Are Evolving To Overcome Zinc Scarcity

doi:10.1021/acsinfecdis.7b00128

Title: Clinical Variants of New Delhi Metallo-β-Lactamase Are Evolving To Overcome Zinc Scarcity

Full Record
Other Related Research

Abstract

Use and misuse of antibiotics have driven the evolution of serine β-lactamases to better recognize new generations of β-lactam drugs, but the selective pressures driving evolution of metallo-β-lactamases are less clear. Here in this paper, we present evidence that New Delhi metallo-β-lactamase (NDM) is evolving to overcome the selective pressure of zinc(II) scarcity. Studies of NDM-1, NDM-4 (M154L), and NDM-12 (M154L, G222D) demonstrate that the point mutant M154L, contained in 50% of clinical NDM variants, selectively enhances resistance to the penam ampicillin at low zinc(II) concentrations relevant to infection sites. Each of the clinical variants is shown to be progressively more thermostable and to bind zinc(II) more tightly than NDM-1, but a selective enhancement of penam turnover at low zinc(II) concentrations indicates that most of the improvement derives from catalysis rather than stability. X-ray crystallography of NDM-4 and NDM-12, as well as bioinorganic spectroscopy of dizinc(II), zinc(II)/cobalt(II), and dicobalt(II) metalloforms probe the mechanism of enhanced resistance and reveal perturbations of the dinuclear metal cluster that underlie improved catalysis. Lastly, these studies support the proposal that zinc(II) scarcity, rather than changes in antibiotic structure, is driving the evolution of new NDM variants in clinical settings.

Authors:

Stewart, Alesha C. ^[1]; Bethel, Christopher R. ^[2]; VanPelt, Jamie ^[3]; Bergstrom, Alex ^[3]; Cheng, Zishuo ^[3]; Miller, Callie G. ^[3]; Williams, Cameron ^[3]; Poth, Robert ^[3]; Morris, Matthew ^[3]; Lahey, Olivia ^[3]; Nix, Jay C. ^[4]; Tierney, David L. ^[3];

^[3];

^[5];

^[1]

Univ. of Texas, Austin, TX (United States). Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, and the LaMontagne Center for Infectious Disease
Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH (United States). Research Services
Miami University, Oxford, OH (United States). Department of Chemistry and Biochemistry
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Molecular Biology Consortium, Beamline 4.2.2, Advanced Light Source
Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH (United States). Research Services ; Departments of Medicine, Pharmacology, Molecular Biology and Microbiology, Biochemistry, Proteomics and Bioinformatics, and the CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology, Cleveland, OH (United States)

Publication Date:: 2017-09-30

Research Org.:: Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)

Sponsoring Org.:: USDOE Office of Science (SC)

OSTI Identifier:: 1426739

Grant/Contract Number:: AC02-05CH11231; AC03-76SF00098

Resource Type:: Accepted Manuscript

Journal Name:: ACS Infectious Diseases

Additional Journal Information:: Journal Volume: 3; Journal Issue: 12; Journal ID: ISSN 2373-8227

Publisher:: American Chemical Society (ACS)

Country of Publication:: United States

Language:: English

Subject:: 59 BASIC BIOLOGICAL SCIENCES; 60 APPLIED LIFE SCIENCES; antibiotic resistance; evolution; nutritional immunity; zinc; β-lactamase

Citation Formats


                    Stewart, Alesha C., Bethel, Christopher R., VanPelt, Jamie, Bergstrom, Alex, Cheng, Zishuo, Miller, Callie G., Williams, Cameron, Poth, Robert, Morris, Matthew, Lahey, Olivia, Nix, Jay C., Tierney, David L., Page, Richard C., Crowder, Michael W., Bonomo, Robert A., and Fast, Walter. Clinical Variants of New Delhi Metallo-β-Lactamase Are Evolving To Overcome Zinc Scarcity.  United States: N. p., 2017. 
        Web.  doi:10.1021/acsinfecdis.7b00128.

Copy to clipboard


                    Stewart, Alesha C., Bethel, Christopher R., VanPelt, Jamie, Bergstrom, Alex, Cheng, Zishuo, Miller, Callie G., Williams, Cameron, Poth, Robert, Morris, Matthew, Lahey, Olivia, Nix, Jay C., Tierney, David L., Page, Richard C., Crowder, Michael W., Bonomo, Robert A., & Fast, Walter. Clinical Variants of New Delhi Metallo-β-Lactamase Are Evolving To Overcome Zinc Scarcity.  United States.  doi:10.1021/acsinfecdis.7b00128.

Copy to clipboard


                    Stewart, Alesha C., Bethel, Christopher R., VanPelt, Jamie, Bergstrom, Alex, Cheng, Zishuo, Miller, Callie G., Williams, Cameron, Poth, Robert, Morris, Matthew, Lahey, Olivia, Nix, Jay C., Tierney, David L., Page, Richard C., Crowder, Michael W., Bonomo, Robert A., and Fast, Walter. Sat .  
        "Clinical Variants of New Delhi Metallo-β-Lactamase Are Evolving To Overcome Zinc Scarcity".  United States.  doi:10.1021/acsinfecdis.7b00128.  https://www.osti.gov/servlets/purl/1426739.

Copy to clipboard


                    
@article{osti_1426739,

  title        = {Clinical Variants of New Delhi Metallo-β-Lactamase Are Evolving To Overcome Zinc Scarcity},

  author       = {Stewart, Alesha C. and Bethel, Christopher R. and VanPelt, Jamie and Bergstrom, Alex and Cheng, Zishuo and Miller, Callie G. and Williams, Cameron and Poth, Robert and Morris, Matthew and Lahey, Olivia and Nix, Jay C. and Tierney, David L. and Page, Richard C. and Crowder, Michael W. and Bonomo, Robert A. and Fast, Walter},

  abstractNote = {Use and misuse of antibiotics have driven the evolution of serine β-lactamases to better recognize new generations of β-lactam drugs, but the selective pressures driving evolution of metallo-β-lactamases are less clear. Here in this paper, we present evidence that New Delhi metallo-β-lactamase (NDM) is evolving to overcome the selective pressure of zinc(II) scarcity. Studies of NDM-1, NDM-4 (M154L), and NDM-12 (M154L, G222D) demonstrate that the point mutant M154L, contained in 50% of clinical NDM variants, selectively enhances resistance to the penam ampicillin at low zinc(II) concentrations relevant to infection sites. Each of the clinical variants is shown to be progressively more thermostable and to bind zinc(II) more tightly than NDM-1, but a selective enhancement of penam turnover at low zinc(II) concentrations indicates that most of the improvement derives from catalysis rather than stability. X-ray crystallography of NDM-4 and NDM-12, as well as bioinorganic spectroscopy of dizinc(II), zinc(II)/cobalt(II), and dicobalt(II) metalloforms probe the mechanism of enhanced resistance and reveal perturbations of the dinuclear metal cluster that underlie improved catalysis. Lastly, these studies support the proposal that zinc(II) scarcity, rather than changes in antibiotic structure, is driving the evolution of new NDM variants in clinical settings.},

  doi          = {10.1021/acsinfecdis.7b00128},

  journal      = {ACS Infectious Diseases},

  number       = 12,

  volume       = 3,

  place        = {United States},

  year         = {2017},

  month        = {9}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (DOE)

Publisher's Version of Record

DOI: 10.1021/acsinfecdis.7b00128

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 11 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Motion of the Zinc Ions in Catalysis by a di-Zinc Metallo-beta-Lactamase

Journal Article Breece, R ; Hu, Z ; Crowder, M ; ... - Journal of the American Chemical Society

We report rapid-freeze-quench X-ray absorption spectroscopy of a dizinc metallo-beta-lactamase (MbetaL) reaction intermediate. The Zn(II) ions in the dinuclear active site of the S. maltophilia Class B3 MbetaL move away from each other, by approximately 0.3 A after 10 ms of reaction with nitrocefin, from 3.4 to 3.7 A. Together with our previous characterization of the resting enzyme and its nitrocefin product complex, where the Zn(II) ion separation relaxes to 3.6 A, these data indicate a scissoring motion of the active site that accompanies the ring-opening step. The average Zn(II) coordination number of 4.5 in the resting enzyme appears tomore »« less
A Noncanonical Metal Center Drives the Activity of the Sediminispirochaeta smaragdinae Metallo-β-lactamase SPS-1

Journal Article Cheng, Zishuo ; VanPelt, Jamie ; Bergstrom, Alexander ; ... - Biochemistry

In an effort to evaluate whether a recently reported putative metallo-β-lactamase (MβL) contains a novel MβL active site, SPS-1 from Sediminispirochaeta smaragdinae was overexpressed, purified, and characterized using spectroscopic and crystallographic studies. Metal analyses demonstrate that recombinant SPS-1 binds nearly 2 equiv of Zn(II), and steady-state kinetic studies show that the enzyme hydrolyzes carbapenems and certain cephalosporins but not β-lactam substrates with bulky substituents at the 6/7 position. Spectroscopic studies of Co(II)-substituted SPS-1 suggest a novel metal center in SPS-1, with a reduced level of spin coupling between the metal ions and a novel Zn ₁ metal binding site. Thismore »« less
Cited by 3
DOI: 10.1021/acs.biochem.8b00728

Full Text Available
Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics

Journal Article Sun, Zhizeng ; Hu, Liya ; Sankaran, Banumathi ; ... - Nature Communications

New Delhi metallo-β-lactamase-1 exhibits a broad substrate profile for hydrolysis of the penicillin, cephalosporin and 'last resort' carbapenems, and thus confers bacterial resistance to nearly all β-lactam antibiotics. Here we address whether the high catalytic efficiency for hydrolysis of these diverse substrates is reflected by similar sequence and structural requirements for catalysis, i.e., whether the same catalytic machinery is used to achieve hydrolysis of each class. Deep sequencing of randomized single codon mutation libraries that were selected for resistance to representative antibiotics reveal stringent sequence requirements for carbapenem versus penicillin or cephalosporin hydrolysis. Further, the residue positions required for hydrolysismore »« less
Cited by 5
DOI: 10.1038/s41467-018-06839-1

Full Text Available
Engineered Mononuclear Variants in Bacillus cereus Metallo-beta-lactamase BcII Are Inactive

Journal Article Abriata, L ; Gonzalez, L ; Llarrull, L ; ... - Biochemistry

Metallo-{beta}-lactamases (M{beta}Ls) are zinc enzymes able to hydrolyze almost all {beta}-lactam antibiotics, rendering them inactive, at the same time endowing bacteria high levels of resistance. The design of inhibitors active against all classes of M{beta}Ls has been hampered by their structural diversity and by the heterogeneity in metal content in enzymes from different sources. BcII is the metallo-{beta}-lactamase from Bacillus cereus, which is found in both the mononuclear and dinuclear forms. Despite extensive studies, there is still controversy about the nature of the active BcII species. Here we have designed two mutant enzymes in which each one of the metalmore »« less
DOI: 10.1021/bi8006912
Structural and Biochemical Evidence That a TEM-1 [beta]-Lactamase N170G Active Site Mutant Acts via Substrate-assisted Catalysis

Journal Article Brown, Nicholas G ; Shanker, Sreejesh ; Prasad, B.V. Venkataram ; ... - J. Biol. Chem.

TEM-1 {beta}-lactamase is the most common plasmid-encoded {beta}-lactamase in Gram-negative bacteria and is a model class A enzyme. The active site of class A {beta}-lactamases share several conserved residues including Ser{sup 70}, Glu{sup 166}, and Asn{sub 170} that coordinate a hydrolytic water involved in deacylation. Unlike Ser{sup 70} and Glu{sup 166}, the functional significance of residue Asn{sup 170} is not well understood even though it forms hydrogen bonds with both Glu{sup 166} and the hydrolytic water. The goal of this study was to examine the importance of Asn{sup 170} for catalysis and substrate specificity of {beta}-lactam antibiotic hydrolysis. The codonmore »« less
DOI: 10.1074/jbc.M109.053819

Similar Records